In a 2024 evaluation of prostate malignant neoplasm mortality across various countries, the United States leads with 34.75 thousand male deaths, exhibiting a year-on-year increase of 1.99%. Following are Brazil (16.46 thousand), Germany (16.07 thousand), and Japan (13.43 thousand), with respective increases of 1.12%, 1.44%, and 1.86%. The United Kingdom records 12.7 thousand deaths, up by 1.33%. Mexico and Peru show significant rise at 7.96 thousand (3.88%) and 4.46 thousand (21.95%) respectively. Conversely, Argentina has seen a decline of -1.46% to 3.54 thousand deaths.
Smaller nations like Luxembourg and Iceland report minimal numbers: 0.056 thousand and 0.062 thousand deaths, respectively. Bulgaria and South Korea show the highest increases on smaller bases at 2.88% and 4.37%. Switzerland and Argentina are notable for negative growth, at -0.45% and -1.46%.
For future trends, watch for technological advancements in healthcare potentially reducing mortality rates. Additionally, countries with significant year-on-year increases might implement stronger healthcare policies aimed at early detection and better management of prostate health.
Top countries in Prostate Malignant Neoplasms Mortality by Country
| # | 10 Countries | Units (Male Deaths) | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 United States | 34,750 | 2023 | +2.09% | +1.99% | View data |
| 2 | 2 Brazil | 16,460 | 2023 | +1.15% | +1.12% | View data |
| 3 | 3 Germany | 16,070 | 2023 | +1.45% | +1.44% | View data |
| 4 | 4 Japan | 13,430 | 2023 | +1.68% | +1.86% | View data |
| 5 | 5 United Kingdom | 12,700 | 2023 | +1.09% | +1.33% | View data |
| 6 | 6 Mexico | 7,960 | 2023 | +2.87% | +3.88% | View data |
| 7 | 7 Poland | 6,180 | 2023 | +2.34% | +2.07% | View data |
| 8 | 8 Spain | 5,940 | 2023 | +0.35% | +0.33% | View data |
| 9 | 9 Canada | 4,680 | 2023 | +1.14% | +1.66% | View data |
| 10 | 10 Peru | 4,460 | 2023 | +15.53% | +21.95% | View data |
